NDC 62908-011

NOEVIR RAYSELA

Zinc Oxide, Octinoxate, Titanium Dioxide

NOEVIR RAYSELA is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Noevir Usa Inc. The primary component is Zinc Oxide; Octinoxate; Titanium Dioxide.

Product ID62908-011_7eebb3b0-6583-47fe-8679-e894f1740645
NDC62908-011
Product TypeHuman Otc Drug
Proprietary NameNOEVIR RAYSELA
Generic NameZinc Oxide, Octinoxate, Titanium Dioxide
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2010-01-01
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameNOEVIR USA INC
Substance NameZINC OXIDE; OCTINOXATE; TITANIUM DIOXIDE
Active Ingredient Strength14250 mg/100g; mg/100g; mg/100g
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 62908-011-02

1 TUBE in 1 BOX (62908-011-02) > 35 g in 1 TUBE (62908-011-01)
Marketing Start Date2010-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 62908-011-02 [62908001102]

NOEVIR RAYSELA CREAM
Marketing Categoryunapproved drug other
Product TypeHUMAN OTC DRUG
Marketing Start Date2010-01-01
Inactivation Date2019-10-21

NDC 62908-011-01 [62908001101]

NOEVIR RAYSELA CREAM
Marketing Categoryunapproved drug other
Product TypeHUMAN OTC DRUG
Marketing Start Date2010-01-01

Drug Details

Active Ingredients

IngredientStrength
ZINC OXIDE14250 mg/100g

OpenFDA Data

SPL SET ID:f63dd9ef-a65a-4d0a-abb9-981f5fd4979c
Manufacturer
UNII

NDC Crossover Matching brand name "NOEVIR RAYSELA" or generic name "Zinc Oxide, Octinoxate, Titanium Dioxide"

NDCBrand NameGeneric Name
62908-011NOEVIR RAYSELAZINC OXIDE, OCTINOXATE, TITANIUM DIOXIDE
62908-012NOEVIR N5ZINC OXIDE, OCTINOXATE, TITANIUM DIOXIDE

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.